Amid Labour’s jubilation over the Supreme Court decision yesterday it would have been easy to miss Jeremy Corbyn’s latest attack on the market economy. But it shouldn’t go unremarked because what Corbyn proposed would seriously damage the pharmaceuticals industry – either meaning that taxpayers would have to bear the enormous costs of developing drugs, or would mean fewer drugs being developed at all.
Corbyn cited the case of nine year old cystic fibrosis sufferer Luis Walker, who is being denied the medicine, Orkambi, because the drugs manufacturer is refusing to sell it to the NHS at an affordable cost. Labour, he said, would end the outrage of drugs companies which put ‘profits for shareholders before people’s lives’ through a policy called ‘Medicines for the Many’, under which drugs companies would be forced to sell drugs at lower prices. He also proposed to set up a publicly-owned drugs company to manufacture generic drugs for the NHS.
The latter is not such a bad proposal, for drugs which are out of patent.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in